Literature DB >> 14557718

Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats.

E M Jutkiewicz1, K C Rice, J H Woods, P J Winsauer.   

Abstract

Delta-opioid receptor agonists produce decreases in immobility in the forced swim test, suggesting that these compounds have antidepressant-like activity. There is also the possibility that these compounds decrease immobility in the forced swim test by disrupting learning processes that occur during the swim, or with successive swim exposures, thus falsely identifying them as having "antidepressant" potential. This study investigated the effects of the delta-opioid receptor agonist, SNC80, on responding in a repeated-acquisition procedure and in the forced swim test in rats, and the effects were compared directly to those of scopolamine, a compound known to disrupt memory and learning. SNC80 disrupted acquisition of a response sequence (learning) and produced a significant antidepressant-like effect in the forced swim test. Scopolamine, however, produced larger decrements in learning without producing behavioral changes consistent with an antidepressant-like profile of action. These results suggest that SNC80 produces antidepressant-like activity through a mechanism independent of its disruptive effects on learning.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557718     DOI: 10.1097/00008877-200311000-00003

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  16 in total

1.  Distinctive modulation of ethanol place preference by delta opioid receptor-selective agonists.

Authors:  Richard M van Rijn; Daniela I Brissett; Jennifer L Whistler
Journal:  Drug Alcohol Depend       Date:  2011-10-21       Impact factor: 4.492

2.  Delta-opioid receptor-mediated modulation of excitability of individual hippocampal neurons: mechanisms involved.

Authors:  Lucia Moravcikova; Roman Moravcik; Daniela Jezova; Lubica Lacinova; Eliyahu Dremencov
Journal:  Pharmacol Rep       Date:  2020-11-08       Impact factor: 3.024

3.  Automated touch screen device for recording complex rodent behaviors.

Authors:  O S Mabrouk; I J Dripps; S Ramani; C Chang; J L Han; K C Rice; E M Jutkiewicz
Journal:  J Neurosci Methods       Date:  2014-06-19       Impact factor: 2.390

Review 4.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 5.  Delta Opioids: Neuroprotective Roles in Preclinical Studies.

Authors:  Shahid Husain
Journal:  J Ocul Pharmacol Ther       Date:  2018 Jan/Feb       Impact factor: 2.671

Review 6.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

7.  In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.

Authors:  B Aguila; L Coulbault; M Boulouard; F Léveillé; A Davis; G Tóth; A Borsodi; G Balboni; S Salvadori; P Jauzac; S Allouche
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

Review 8.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

9.  Delta opioid receptor ligands modulate anxiety-like behaviors in the rat.

Authors:  Shane A Perrine; Brian A Hoshaw; Ellen M Unterwald
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

10.  Different affective response to opioid withdrawal in adolescent and adult mice.

Authors:  Stephen R Hodgson; Rebecca S Hofford; Paul J Wellman; Shoshana Eitan
Journal:  Life Sci       Date:  2008-11-12       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.